Terms: = Germ cell tumor AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9 AND Clinical Outcome
36 results:
1. Well-differentiated gastro-entero-pancreatic neuroendocrine tumors with positive FDG-PET/CT: a retrospective chart review.
Haidar M; Al Mahmasani L; Chehade L; Elias C; El Jebai M; Temraz S; Charafeddine M; Al Darazi M; Shamseddine A
Nucl Med Commun; 2023 Jun; 44(6):471-479. PubMed ID: 36897058
[TBL] [Abstract] [Full Text] [Related]
2. Impact of extent of resection and adjuvant therapy in diffuse gliomas of the spine.
Chalif EJ; Foster C; Sack K; Patrick H; Mozaffari K; Rosner M
Spine J; 2023 Jul; 23(7):1015-1027. PubMed ID: 36804437
[TBL] [Abstract] [Full Text] [Related]
3. Combined PD-1, BRAF and MEK inhibition in BRAF
Tian J; Chen JH; Chao SX; Pelka K; Giannakis M; Hess J; Burke K; Jorgji V; Sindurakar P; Braverman J; Mehta A; Oka T; Huang M; Lieb D; Spurrell M; Allen JN; Abrams TA; Clark JW; Enzinger AC; Enzinger PC; Klempner SJ; McCleary NJ; Meyerhardt JA; Ryan DP; Yurgelun MB; Kanter K; Van Seventer EE; Baiev I; Chi G; Jarnagin J; Bradford WB; Wong E; Michel AG; Fetter IJ; Siravegna G; Gemma AJ; Sharpe A; Demehri S; Leary R; Campbell CD; Yilmaz O; Getz GA; Parikh AR; Hacohen N; Corcoran RB
Nat Med; 2023 Feb; 29(2):458-466. PubMed ID: 36702949
[TBL] [Abstract] [Full Text] [Related]
4. MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis.
Alborzinia H; Flórez AF; Kreth S; Brückner LM; Yildiz U; Gartlgruber M; Odoni DI; Poschet G; Garbowicz K; Shao C; Klein C; Meier J; Zeisberger P; Nadler-Holly M; Ziehm M; Paul F; Burhenne J; Bell E; Shaikhkarami M; Würth R; Stainczyk SA; Wecht EM; Kreth J; Büttner M; Ishaque N; Schlesner M; Nicke B; Stresemann C; Llamazares-Prada M; Reiling JH; Fischer M; Amit I; Selbach M; Herrmann C; Wölfl S; Henrich KO; Höfer T; Trumpp A; Westermann F
Nat Cancer; 2022 Apr; 3(4):471-485. PubMed ID: 35484422
[TBL] [Abstract] [Full Text] [Related]
5. Endoscopic-assisted surgical approach for butterfly glioma surgery.
Dadario NB; Zaman A; Pandya M; Dlouhy BJ; Gunawardena MP; Sughrue ME; Teo C
J Neurooncol; 2022 Feb; 156(3):635-644. PubMed ID: 35032284
[TBL] [Abstract] [Full Text] [Related]
6. Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial.
Forde PM; Anagnostou V; Sun Z; Dahlberg SE; Kindler HL; Niknafs N; Purcell T; Santana-Davila R; Dudek AZ; Borghaei H; Lanis M; Belcaid Z; Smith KN; Balan A; White JR; Cherry C; Ashok Sivakumar IK; Shao XM; Chan HY; Singh D; Thapa S; Illei PB; Pardoll DM; Karchin R; Velculescu VE; Brahmer JR; Ramalingam SS
Nat Med; 2021 Nov; 27(11):1910-1920. PubMed ID: 34750557
[TBL] [Abstract] [Full Text] [Related]
7. Typical and Atypical Carcinoid tumors of the Mediastinum: A Biomarker Analysis of 27 Cases With clinical Correlation.
Zaleski M; Kalhor N; Moran CA
Int J Surg Pathol; 2021 Jun; 29(4):358-367. PubMed ID: 33243039
[TBL] [Abstract] [Full Text] [Related]
8. Expression of GNAS, TP53, and PTEN Improves the Patient Prognostication in Sonic Hedgehog (SHH) Medulloblastoma Subgroup.
da Silva LS; Mançano BM; de Paula FE; Dos Reis MB; de Almeida GC; Matsushita M; Junior CA; Evangelista AF; Saggioro F; Serafini LN; Stavale JN; Malheiros SMF; Lima M; Hajj GNM; de Lima MA; Taylor MD; Leal LF; Reis RM
J Mol Diagn; 2020 Jul; 22(7):957-966. PubMed ID: 32380172
[TBL] [Abstract] [Full Text] [Related]
9. Molecular risk prediction in cutaneous melanoma: A meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients.
Greenhaw BN; Covington KR; Kurley SJ; Yeniay Y; Cao NA; Plasseraud KM; Cook RW; Hsueh EC; Gastman BR; Wei ML
J Am Acad Dermatol; 2020 Sep; 83(3):745-753. PubMed ID: 32229276
[TBL] [Abstract] [Full Text] [Related]
10. Patterns of care and clinical outcome in assumed glioblastoma without tissue diagnosis: A population-based study of 131 consecutive patients.
Werlenius K; Fekete B; Blomstrand M; Carén H; Jakola AS; Rydenhag B; Smits A
PLoS One; 2020; 15(2):e0228480. PubMed ID: 32053655
[TBL] [Abstract] [Full Text] [Related]
11. 18F-Fluciclovine PET/CT in Suspected Residual or Recurrent High-Grade Glioma.
Bogsrud TV; Londalen A; Brandal P; Leske H; Panagopoulos I; Borghammer P; Bach-Gansmo T
Clin Nucl Med; 2019 Aug; 44(8):605-611. PubMed ID: 31274605
[TBL] [Abstract] [Full Text] [Related]
12. Correlation of radiological and immunochemical parameters with clinical outcome in patients with recurrent glioblastoma treated with Bevacizumab.
Manneh Kopp RA; Sepúlveda-Sánchez JM; Ruano Y; Toldos O; Pérez Núñez A; Cantero D; Hilario A; Ramos A; de Velasco G; Sánchez-Gómez P; Hernández-Laín A
Clin Transl Oncol; 2019 Oct; 21(10):1413-1423. PubMed ID: 30877636
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic factors of patients with gastroenteropancreatic neuroendocrine neoplasms.
Huang PY; Tsai KL; Liang CM; Tai WC; Rau KM; Wu KL; Huang CC; Chuah SK
Kaohsiung J Med Sci; 2018 Nov; 34(11):650-656. PubMed ID: 30392572
[TBL] [Abstract] [Full Text] [Related]
14. Wide Range of clinical outcomes in Patients with Gliomatosis Cerebri Growth Pattern: A clinical, Radiographic, and Histopathologic Study.
Ly KI; Oakley DH; Pine AB; Frosch MP; Chiou SH; Betensky RA; Pomerantz SR; Hochberg FH; Batchelor TT; Cahill DP; Dietrich J
Oncologist; 2019 Mar; 24(3):402-413. PubMed ID: 30097523
[TBL] [Abstract] [Full Text] [Related]
15. A kinome-wide RNAi screen identifies ALK as a target to sensitize neuroblastoma cells for HDAC8-inhibitor treatment.
Shen J; Najafi S; Stäble S; Fabian J; Koeneke E; Kolbinger FR; Wrobel JK; Meder B; Distel M; Heimburg T; Sippl W; Jung M; Peterziel H; Kranz D; Boutros M; Westermann F; Witt O; Oehme I
Cell Death Differ; 2018 Dec; 25(12):2053-2070. PubMed ID: 29515255
[TBL] [Abstract] [Full Text] [Related]
16. Ventriculoscopic Surgery for Cystic Retrochiasmatic Craniopharyngiomas: Indications, Surgical Technique, and Short-Term Patient outcomes.
Hollon TC; Savastano LE; Altshuler D; Barkan AL; Sullivan SE
Oper Neurosurg (Hagerstown); 2018 Aug; 15(2):109-119. PubMed ID: 29048572
[TBL] [Abstract] [Full Text] [Related]
17. Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to clinical outcomes.
Ko JS; Matharoo-Ball B; Billings SD; Thomson BJ; Tang JY; Sarin KY; Cai E; Kim J; Rock C; Kimbrell HZ; Flake DD; Warf MB; Nelson J; Davis T; Miller C; Rushton K; Hartman AR; Wenstrup RJ; Clarke LE
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1107-1113. PubMed ID: 28377414
[No Abstract] [Full Text] [Related]
18. Associations between clinical outcome and navigated transcranial magnetic stimulation characteristics in patients with motor-eloquent brain lesions: a combined navigated transcranial magnetic stimulation-diffusion tensor imaging fiber tracking approach.
Sollmann N; Wildschuetz N; Kelm A; Conway N; Moser T; Bulubas L; Kirschke JS; Meyer B; Krieg SM
J Neurosurg; 2018 Mar; 128(3):800-810. PubMed ID: 28362239
[TBL] [Abstract] [Full Text] [Related]
19. Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813.
Chang S; Zhang P; Cairncross JG; Gilbert MR; Bahary JP; Dolinskas CA; Chakravarti A; Aldape KD; Bell EH; Schiff D; Jaeckle K; Brown PD; Barger GR; Werner-Wasik M; Shih H; Brachman D; Penas-Prado M; Robins HI; Belanger K; Schultz C; Hunter G; Mehta M
Neuro Oncol; 2017 Feb; 19(2):252-258. PubMed ID: 27994066
[TBL] [Abstract] [Full Text] [Related]
20. Gamma Knife radiosurgery for brain metastases from pulmonary large cell neuroendocrine carcinoma: a Japanese multi-institutional cooperative study (JLGK1401).
Kawabe T; Yamamoto M; Sato Y; Yomo S; Kondoh T; Nagano O; Serizawa T; Tsugawa T; Okamoto H; Akabane A; Aita K; Sato M; Jokura H; Kawagishi J; Shuto T; Kawai H; Moriki A; Kenai H; Iwai Y; Gondo M; Hasegawa T; Yasuda S; Kikuchi Y; Nagatomo Y; Watanabe S; Hashimoto N
J Neurosurg; 2016 Dec; 125(Suppl 1):11-17. PubMed ID: 27903179
[TBL] [Abstract] [Full Text] [Related]
[Next]
